Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
VERV - TAX PROVISION
Tax Provision VERV - Verve Therapeutics, Inc.
275 K
LAST VALUE
47.10%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR